Zenabis joins Shoppers Drug Mart Pilot Project to bring
Greater Intelligence to Medical Cannabis
TruTrace Technologies Inc. (CSE: TTT) (OTC: TTTSF) (“TruTrace” or the “Company“), creator of the first fully-integrated blockchain platform that registers and tracks intellectual property for the cannabis industry, today announced that Zenabis Global Inc. (TSX:ZENA) (“Zenabis“), a Canadian licensed cultivator of medical and recreational cannabis, will employ the Company’s StrainSecure™ platform to collect, register, manage, track and publish verified testing data of its cannabis plant DNA and strains.
Use of the StrainSecure platform is intended to enable Zenabis to validate its cannabis strains and provide its customers with increased transparency about the authenticity, quality and origin of its products. In addition, Zenabis is joining the Shoppers Drug Mart (“Shoppers“) and TruTrace medical cannabis verification pilot project (the “Pilot Project“) announced last week at the World Cannabis Congress. Shoppers aims to improve industry accountability and patient outcomes through the Pilot Project.
“This initiative continues to gain momentum with the signing of a forward-thinking cannabis cultivator like Zenabis who recognizes the value of providing verified product data to their patients and customers,” said TruTrace Technologies CEO Robert Galarza. “The recent launch of this traceability pilot project with Canada’s leading pharmacy brand demonstrates the importance of standardization and traceability in designing and evaluating treatment programs for patients.”
Zenabis’ Chief Revenue Officer, David Lluncor, added, “We’re extremely excited to be part of the pioneer group of licensed producers partnered with TruTrace Technologies and Shoppers Drug Mart, who are committed to increasing transparency, traceability, and standardization in the cannabis industry. In particular, we’re happy to be able to play a role in offering Canadian medical patients and adult-use consumers assurances that they are being supplied safe, high quality, cannabis and hemp CBD products.”
Under the StrainSecure program, the TruTrace team collects plant testing data and performs genomic verification in plant batches which are then registered in a blockchain-enabled database for intellectual property protection and strain validation. All information gathered from the plants, including their molecular and chemical makeup, can be tracked via the program.
TruTrace Technologies has signed multiple licensed producers to the StrainSecure platform since the start of 2019, and is engaged with partners of all types in support of the Pilot Project.
Phase 1 of the Pilot Project is expected to be completed by July 31, with full production and implementation targeted for late November 2019.
About TruTrace Technologies:
TruTrace Technologies has developed the first integrated blockchain platform to register and track intellectual property in the cannabis industry. TruTrace’s technology allows cannabis growers and breeders to identify and secure rights to their intellectual property. It also streamlines the administrative process and reduces the costs of genetic and mandatory quality-control testing for legal cannabis. TruTrace’s technology is proprietary, immutable and cryptographically secure, thereby establishing an accurate and permanent account for cannabis strains from ownership to market.
Zenabis is a significant Canadian licensed cannabis cultivator of medical and recreational cannabis, and a propagator and cultivator of floral and vegetable products. Zenabis employs staff coast-to-coast, across facilities in Atholville, New Brunswick; Delta, Aldergrove, Pitt Meadows and Langley, British Columbia; and Stellarton, Nova Scotia. In addition to gaining technologically advanced knowledge of plant propagation, the recent addition of state-of-the-art greenhouses in Langley, Pitt Meadows and Aldergrove provides Zenabis with 3.5 million square feet of facility space that can, upon full conversion, be dedicated to cannabis production.